Crovalimab-akkz (Piasky)
Dilution requiredFull monograph review pending
U.S. label preparation
Piasky · Dilution required
- Preparation
- For the first IV dose, dilute in a 100 or 250 mL bag of 0.9% sodium chloride to 4-15 mg/mL. Table 2 gives dose-specific examples.
- Administration and handling
- Subsequent doses are given subcutaneously without dilution. Follow the route-specific instructions and vaccination requirements.
Product and source details
Genentech, Inc. · BLA761388
Product NDC: 50242-115
SPL effective 2025-11-11 | SPL version 3. Checked 2026-11-13.
Source for this summary: U.S. prescribing information. Use the full label for dose selection, contraindications, preparation tables and monitoring.
Product identifiers and clinical review status
U.S. label preparation available. Full monograph review pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Obtain independent corroboration of the label preparation where available.
- Complete indication- and age-specific dosing, incompatibility, monitoring and stability review.
- Assess any proposed compounding BUD for the exact formulation, concentration, container and conditions.